Victrex (LON:VCT) Downgraded by Canaccord Genuity Group to Buy

Canaccord Genuity Group downgraded shares of Victrex (LON:VCTFree Report) to a buy rating in a research report released on Friday, MarketBeat.com reports. The firm currently has GBX 725 target price on the stock.

Other research analysts have also recently issued research reports about the stock. UBS Group restated a “sell” rating and issued a GBX 575 target price on shares of Victrex in a research report on Monday, May 11th. JPMorgan Chase & Co. decreased their price objective on Victrex from GBX 725 to GBX 625 and set a “buy” rating for the company in a report on Wednesday, March 18th. Finally, Jefferies Financial Group cut their target price on Victrex from GBX 675 to GBX 595 and set a “hold” rating on the stock in a research note on Tuesday. Two equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of GBX 702.86.

Check Out Our Latest Analysis on VCT

Victrex Stock Performance

VCT stock opened at GBX 581 on Friday. Victrex has a 1 year low of GBX 515 and a 1 year high of GBX 834. The stock has a market capitalization of £506.19 million, a price-to-earnings ratio of 18.27, a PEG ratio of 1.92 and a beta of 0.75. The company has a debt-to-equity ratio of 21.30, a quick ratio of 1.99 and a current ratio of 2.35. The stock’s fifty day moving average is GBX 600.81 and its two-hundred day moving average is GBX 641.91.

Victrex (LON:VCTGet Free Report) last released its quarterly earnings results on Monday, May 11th. The company reported GBX 17.20 EPS for the quarter. Victrex had a negative net margin of 6.70% and a negative return on equity of 4.95%. The business had revenue of £147.10 million during the quarter. On average, research analysts predict that Victrex will post 73.1078905 EPS for the current year.

About Victrex

(Get Free Report)

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.

Further Reading

Analyst Recommendations for Victrex (LON:VCT)

Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.